Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types
Anti-p53 antibodies are antibodies that mistakenly target a patient’s own tissues, leading to a growth of solid tumors. Screening for Anti-p53 helps to diagnose throat, bowel and breast cancers earlier, thereby increasing the chances that a patient responds to a treatment The Elecsys Anti-p53 could be used to monitor cancer cell remnants in the patient’s... Read more